These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24030133)

  • 21. Recommended composition of influenza virus vaccines for use in the 2012–2013 northern hemisphere influenza season.
    Wkly Epidemiol Rec; 2012 Mar; 87(10):83-95. PubMed ID: 22462202
    [No Abstract]   [Full Text] [Related]  

  • 22. Recommended composition of influenza vaccines for use in the 2012 southern hemisphere influenza season.
    Wkly Epidemiol Rec; 2011 Oct; 86(42):457-68. PubMed ID: 22046594
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age.
    Baxter R; Patriarca PA; Ensor K; Izikson R; Goldenthal KL; Cox MM
    Vaccine; 2011 Mar; 29(12):2272-8. PubMed ID: 21277410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza vaccination for older adults.
    Talbot HK; Libster R; Edwards KM
    Hum Vaccin Immunother; 2012 Jan; 8(1):96-101. PubMed ID: 22252003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recommended composition of influenza virus vaccines for use in the 2013 southern hemisphere influenza season.
    Wkly Epidemiol Rec; 2012 Oct; 87(41):389-400. PubMed ID: 23074737
    [No Abstract]   [Full Text] [Related]  

  • 26. Recommended composition of influenza virus vaccines for use in the 2008 influenza season.
    Wkly Epidemiol Rec; 2007 Oct; 82(40):351-6. PubMed ID: 17918656
    [No Abstract]   [Full Text] [Related]  

  • 27. Mortality benefits of influenza vaccination in elderly people.
    Thijs C; Beyer WE; Govaert PM; Sprenger MJ; Dinant GJ; Knottnerus A
    Lancet Infect Dis; 2008 Aug; 8(8):460-1; author reply 463-5. PubMed ID: 18652989
    [No Abstract]   [Full Text] [Related]  

  • 28. Recommended composition of influenza virus vaccines for use in the 2009-2010 influenza season (northern hemisphere winter).
    Wkly Epidemiol Rec; 2009 Feb; 84(9):65-72. PubMed ID: 19248288
    [No Abstract]   [Full Text] [Related]  

  • 29. Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes.
    Pushko P; Pearce MB; Ahmad A; Tretyakova I; Smith G; Belser JA; Tumpey TM
    Vaccine; 2011 Aug; 29(35):5911-8. PubMed ID: 21723354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recommended composition of influenza virus vaccines for use in the 2014 southern hemisphere influenza season.
    Wkly Epidemiol Rec; 2013 Oct; 88(41):437-48. PubMed ID: 24159667
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy of single versus boost vaccination against influenza virus in patients with multiple myeloma.
    Hahn M; Schnitzler P; Schweiger B; Kunz C; Ho AD; Goldschmidt H; Schmitt M
    Haematologica; 2015 Jul; 100(7):e285-8. PubMed ID: 25820335
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative efficacy of influenza vaccines.
    Narayan KM; del Rio C
    N Engl J Med; 2010 Jan; 362(2):179-80; author reply 180-1. PubMed ID: 20071712
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative efficacy of influenza vaccines.
    Linder J
    N Engl J Med; 2010 Jan; 362(2):180; author reply 180-1. PubMed ID: 20077593
    [No Abstract]   [Full Text] [Related]  

  • 34. Recommended composition of influenza virus vaccines for use in the 2015 southern hemisphere influenza season.
    Wkly Epidemiol Rec; 2014 Oct; 89(41):441-55. PubMed ID: 25313423
    [No Abstract]   [Full Text] [Related]  

  • 35. Recommendations for prevention and control of influenza in children, 2013-2014.
    Committee on infectious diseases
    Pediatrics; 2013 Oct; 132(4):e1089-104. PubMed ID: 23999962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recommended composition of influenza virus vaccines for use in the 2017 southern hemisphere influenza season.
    Wkly Epidemiol Rec; 2016 Oct; 91(41):469-84. PubMed ID: 27758094
    [No Abstract]   [Full Text] [Related]  

  • 37. Recommended composition of influenza virus vaccines for use in the 2017–2018 northern hemisphere influenza season.
    Wkly Epidemiol Rec; 2017 Mar; 92(11):117-28. PubMed ID: 28303704
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of intranasal live attenuated influenza vaccine in individuals with asthma or a history of wheezing.
    Ambrose CS
    Hum Vaccin Immunother; 2012 Feb; 8(2):279; author reply 280. PubMed ID: 22426366
    [No Abstract]   [Full Text] [Related]  

  • 39. The 3rd international conference on Influenza Vaccines for the World (IVW 2009).
    Yedidia TB
    Hum Vaccin; 2009 Aug; 5(8):508-9. PubMed ID: 19556873
    [No Abstract]   [Full Text] [Related]  

  • 40. [The influenza season 2004/'05 in the Netherlands with the largest epidemic of the last 5 years caused by the virus variant A/California and the composition of the vaccine for the season 2005/'06].
    de Jong JC; Rimmelzwaan GF; Bartelds AI; Meijer A; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2005 Oct; 149(42):2355-61. PubMed ID: 16261717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.